These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 32589362
1. A single-arm study of systemic and sub-Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Jubran RF, Villablanca JG, Krailo M, Piao J, Huang L, Murphree AL, O'Brien J, Gombos D, Shields CL, Meadows A, Chintagumpala M. Pediatr Blood Cancer; 2020 Sep; 67(9):e28502. PubMed ID: 32589362 [Abstract] [Full Text] [Related]
2. Prospective phase II study of children affected by bilateral intraocular retinoblastoma with macular involvement of both eyes or in the only preserved eye. Macular tumor control, eye preservation rate, and visual outcome. Russo I, Levy-Gabriel C, Dupont A, Lumbroso-Le Rouic L, Cassoux N, Desjardins L, Bertozzi AI, Coze C, Doz F, Savignoni A, Aerts I. Pediatr Blood Cancer; 2021 Jan; 68(1):e28721. PubMed ID: 33098751 [Abstract] [Full Text] [Related]
3. Management and outcome of retinoblastoma with vitreous seeds. Manjandavida FP, Honavar SG, Reddy VA, Khanna R. Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675 [Abstract] [Full Text] [Related]
4. Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group. Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT. Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28019092 [Abstract] [Full Text] [Related]
5. Treatment of intraocular retinoblastoma with vincristine and carboplatin. Rodriguez-Galindo C, Wilson MW, Haik BG, Merchant TE, Billups CA, Shah N, Cain A, Langston J, Lipson M, Kun LE, Pratt CB. J Clin Oncol; 2003 May 15; 21(10):2019-25. PubMed ID: 12743157 [Abstract] [Full Text] [Related]
6. Chemoreduction for unilateral retinoblastoma. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ. Arch Ophthalmol; 2002 Dec 15; 120(12):1653-8. PubMed ID: 12470138 [Abstract] [Full Text] [Related]
7. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, Bunin GR, Meadows AT. J Clin Oncol; 2000 Jan 15; 18(1):12-7. PubMed ID: 10623688 [Abstract] [Full Text] [Related]
8. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ. Am J Ophthalmol; 2002 May 15; 133(5):657-64. PubMed ID: 11992863 [Abstract] [Full Text] [Related]
9. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma. Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S. Pediatr Blood Cancer; 2008 Mar 15; 50(3):567-72. PubMed ID: 17729249 [Abstract] [Full Text] [Related]
10. Evaluating primary intra-arterial chemotherapy versus intravenous plus intra-arterial chemotherapy for advanced intraocular retinoblastoma. Chen Q, Zhang B, Dong Y, Mo X, Zhang L, Xia J, Zhang J, Zhang S. Cancer Chemother Pharmacol; 2020 Apr 15; 85(4):723-730. PubMed ID: 32123960 [Abstract] [Full Text] [Related]
11. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma. Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL. Pediatr Blood Cancer; 2013 May 15; 60(5):766-70. PubMed ID: 23024125 [Abstract] [Full Text] [Related]
12. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct 15; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]
13. Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. Fabian ID, Stacey AW, Johnson KP, Onadim Z, Chowdhury T, Duncan C, Reddy MA, Sagoo MS. Br J Ophthalmol; 2017 Jan 15; 101(1):82-88. PubMed ID: 27965263 [Abstract] [Full Text] [Related]
15. First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma. Beck MN, Balmer A, Dessing C, Pica A, Munier F. J Clin Oncol; 2000 Aug 15; 18(15):2881-7. PubMed ID: 10920136 [Abstract] [Full Text] [Related]
16. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Ophthalmology; 2010 Aug 15; 117(8):1623-9. PubMed ID: 20381868 [Abstract] [Full Text] [Related]
17. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar 15; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
18. The success of primary chemotherapy for group D heritable retinoblastoma. Cohen VM, Kingston J, Hungerford JL. Br J Ophthalmol; 2009 Jul 15; 93(7):887-90. PubMed ID: 18703556 [Abstract] [Full Text] [Related]
19. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Shields CL, Shields JA, Needle M, de Potter P, Kheterpal S, Hamada A, Meadows AT. Ophthalmology; 1997 Dec 15; 104(12):2101-11. PubMed ID: 9400771 [Abstract] [Full Text] [Related]
20. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Lambert MP, Shields C, Meadows AT. Pediatr Blood Cancer; 2008 Feb 15; 50(2):223-6. PubMed ID: 17278120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]